CAS, a division of the American Chemical Society, 2540 Olentangy River Rd, Columbus, Ohio 43202, United States.
Bayer Consumer Health, R&D Digestive Health, Darmstadt 64295, Germany.
ACS Chem Neurosci. 2023 May 17;14(10):1717-1763. doi: 10.1021/acschemneuro.3c00127. Epub 2023 May 8.
Gut microbiota includes a vast collection of microorganisms residing within the gastrointestinal tract. It is broadly recognized that the gut and brain are in constant bidirectional communication, of which gut microbiota and its metabolic production are a major component, and form the so-called gut microbiome-brain axis. Disturbances of microbiota homeostasis caused by imbalance in their functional composition and metabolic activities, known as dysbiosis, cause dysregulation of these pathways and trigger changes in the blood-brain barrier permeability, thereby causing pathological malfunctions, including neurological and functional gastrointestinal disorders. In turn, the brain can affect the structure and function of gut microbiota through the autonomic nervous system by regulating gut motility, intestinal transit and secretion, and gut permeability. Here, we examine data from the CAS Content Collection, the largest collection of published scientific information, and analyze the publication landscape of recent research. We review the advances in knowledge related to the human gut microbiome, its complexity and functionality, its communication with the central nervous system, and the effect of the gut microbiome-brain axis on mental and gut health. We discuss correlations between gut microbiota composition and various diseases, specifically gastrointestinal and mental disorders. We also explore gut microbiota metabolites with regard to their impact on the brain and gut function and associated diseases. Finally, we assess clinical applications of gut-microbiota-related substances and metabolites with their development pipelines. We hope this review can serve as a useful resource in understanding the current knowledge on this emerging field in an effort to further solving of the remaining challenges and fulfilling its potential.
肠道微生物群包括居住在胃肠道内的大量微生物。人们广泛认识到,肠道和大脑之间存在持续的双向交流,其中肠道微生物群及其代谢产物是一个主要组成部分,并形成所谓的肠道微生物群-脑轴。由于其功能组成和代谢活动的失衡而导致的微生物群平衡失调,即失调,会导致这些途径的失调,并引发血脑屏障通透性的变化,从而导致病理性功能障碍,包括神经和功能性胃肠道疾病。反过来,大脑可以通过调节肠道蠕动、肠道转运和分泌以及肠道通透性,通过自主神经系统影响肠道微生物群的结构和功能。在这里,我们检查了 CAS 内容集(发布的最大科学信息集合)的数据,并分析了最近研究的出版格局。我们回顾了与人类肠道微生物群相关的知识进展,其复杂性和功能,它与中枢神经系统的通讯,以及肠道微生物群-脑轴对精神和肠道健康的影响。我们讨论了肠道微生物群组成与各种疾病之间的相关性,特别是胃肠道和精神障碍。我们还研究了肠道微生物群代谢物对大脑和肠道功能及相关疾病的影响。最后,我们评估了与肠道微生物群相关的物质和代谢物的临床应用及其开发管道。我们希望本综述可以作为理解这一新兴领域当前知识的有用资源,以努力进一步解决剩余的挑战并发挥其潜力。